文献速递心脏核医学

西班牙核心脏病学实践

Nuclear cardiology practice in Spain.
PubMed 文献 · J Nucl Cardiol · 2017-05-10

西班牙核医学与分子影像学会核心脏病学工作组邀请全国核医学科填写2014年度在线问卷,收集42个中心40161例患者数据。公立医院核心脏病学年活动量估计为每千人2项检查,其中69%为SPECT心肌灌注显像。结论指出西班牙核心脏病学的主要挑战是逐步采用高灵敏度低剂量专用心脏SPECT相机、扩大心脏PET应用及获得心肌灌注显像示踪剂。

要点

  • 42个中心共收集40161例患者数据,应答公立中心服务西班牙39%人口。
  • 公立医院核心脏病学年活动量估计为每千人2项检查/年。
  • 核心脏病学操作中69%为SPECT心肌灌注显像,17%为平衡法心室造影,12%为18F-FDG PET。

核心结论

  • 西班牙核心脏病学的主要挑战是逐步采用高灵敏度、低剂量专用心脏SPECT相机,扩大心脏PET应用并增加相机数量,以及获得心肌灌注显像示踪剂并配套存活/炎症显像设置。

研究设计与样本

  • 西班牙核医学与分子影像学会核心脏病学工作组邀请全国核医学科回答关于2014年度活动的在线问卷。
  • 共收集42个中心40161例患者的数据。
  • 应答公立中心服务西班牙39%的人口。

主要发现

  • 公立医院核心脏病学活动量估计为每千人2项检查/年。
  • 全部核心脏病学操作中69%为SPECT心肌灌注显像,17%为平衡法心室造影,12%为18F-FDG PET,1.3%为首次通过心室造影,神经支配显像和淀粉样变性显像各<1%。
  • 最常见的核心脏病学检查为99mTc示踪剂、运动负荷、2天法心肌灌注显像心电图门控SPECT,由心脏科医生为门诊患者诊断目的开具,平均等待时间21天,负荷阶段由心脏科医生和核医学医生共同监督,由核医学医生撰写完整报告。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In Spain, nuclear cardiology (NC) procedures represent the second most frequently performed studies in nuclear medicine (NM) centers. METHODS: The NC Working Group of the Spanish Society of Nuclear Medicine and Molecular Imaging invited NM departments across the country to answer an online questionnaire regarding 2014 activity. RESULTS: Data on 40,161 patients from 42 centers were collected. The responding public centers served 39% of Spain´s population. The estimated NC activity for public hospitals was 2 studies/1,000 population/year. Of all the NC procedures, 69% were SPECT myocardial perfusion imaging (MPI), 17% equilibrium ventriculography, 12% 18F-FDG PET, 1.3% first pass ventriculography, and <1% innervation and amyloidosis imaging, respectively. The most frequent NC study was a 99mTc tracer, exercise, 2-day MPI ECG-gated SPECT ordered by a cardiologist for diagnosis in an outpatient with 21 days of mean waiting time, the stress phase being supervised by both a cardiologist and a NM physician, with a NM physician writing a complete report. CONCLUSIONS: A major challenge for NC in Spain is the gradual adoption of high-sensitivity, low-dose-dedicated cardiac SPECT cameras and the broadening of cardiac PET utilization with more cameras, and the availability of MPI tracers alongside the viability/inflammation setup.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Jimenez-Heffernan A, Aguade-Bruix S, Casans-Tormo I, et al. Nuclear cardiology practice in Spain. J Nucl Cardiol. 2017. PMID: 28493201. doi:10.1007/s12350-017-0912-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。